REVERSED-PHASE LIQUID-CHROMATOGRAPHIC DETERMINATION OF IDARUBICIN AND ITS 13-HYDROXY METABOLITE IN HUMAN-PLASMA

被引：21

作者：

EKSBORG, S

NILSSON, B

机构：

来源：

JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 1989年 / 488卷 / 02期

关键词：

D O I：

10.1016/S0378-4347(00)82966-7

中图分类号：

O65 [分析化学];

学科分类号：

070302 ; 081704 ;

摘要：

引用

页码：427 / 434

页数：8

共 17 条

[1]

CARELLA AM, 1985, CANCER, V55, P1452, DOI 10.1002/1097-0142(19850401)55:7<1452::AID-CNCR2820550705>3.0.CO

[2]

2-D

[3] A PHASE-II STUDY OF IDARUBICIN (4-DEMETHOXYDAUNORUBICIN) IN ADVANCED MYELOMA [J].

CHISESI, T ;

CAPNIST, G ;

DEDOMINICIS, E ;

DINI, E .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (04) :681-684

[4]

CUMMINGS J, 1987, CANCER CHEMOTH PHARM, V19, P296

[5]

DAGHESTANI AN, 1985, CANCER RES, V45, P1408

[6] EFFECT OF DAUNORUBICIN, CARMINOMYCIN, IDARUBICIN AND 4-DEMETHOXYDAUNORUBICINOL AGAINST HUMAN NORMAL MYELOID STEM-CELLS AND HUMAN-MALIGNANT CELLS-INVITRO [J].

DODION, P ;

SANDERS, C ;

ROMBAUT, W ;

MATTELAER, MA ;

ROZENCWEIG, M ;

STRYCKMANS, P ;

KENIS, Y .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (12) :1909-1914

[7]

EKSBORG S, 1978, J CHROMATOGR, V149, P225, DOI 10.1016/S0021-9673(00)80988-7

[8]

Eksborg S, 1984, J Pharm Biomed Anal, V2, P297, DOI 10.1016/0731-7085(84)80080-1

[9]

EKSBORG S, 1981, ACTA PHARM SUEC, V18, P215

[10] LIQUID-CHROMATOGRAPHIC DETERMINATION OF DAUNORUBICIN AND DAUNORUBICINOL IN PLASMA FROM LEUKEMIC PATIENTS [J].

EKSBORG, S ;

EHRSSON, H ;

ANDERSSON, B ;

BERAN, M .

JOURNAL OF CHROMATOGRAPHY, 1978, 153 (01) :211-218

← 1 2 →